|
|
|
|
|
|
|
|
open access
Patients and Methods
After obtaining the Ethics Committee approval (No. 43/2015) we retrospectively reviewed data of patients submitted to surgery for advanced stage or recurrent ovarian cancer at the Dan Setlacec Center of Gastrointestinal Disease and Liver Transplantation, Fundeni Clinical Institute, Romania, between January 2002 and May 2014 and found six cases eligible for the study: one case who was submitted to pancreatic resection at the moment of primary cytoreduction, four cases submitted to pancreatic surgery as part of secondary cytoreduction and another patient submitted to pancreatic surgery during tertiary cytoreduction......
Conclusion
Pancreatic resections can and should be
performed as part of cytoreductive surgery for patients with
advanced-stage or relapsed
ovarian cancer. Although pancreatic fistula is a
common complication after this type of surgery, this fact should not be
transformed
into a contraindication for pancreatic surgery in
the context of advanced gynecological malignancies, a good understanding
of this complication being mandatory in order to
treat it successfully with minimal impact on the postoperative outcomes.
Once the pancreatic fistula is assessed, the
patient can be safely submitted to adjuvant chemotherapy to maximize the
benefits
provided by complete surgical cytoreduction.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.